Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

nork Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Argitaratua izan da Diabetes Obes Metab (2016)

Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.

nork Ohgaki, H, Hasegawa, H, Kato, T, Suenaga, M, Ubukata, M, Sato, S, Takayama, S, Sugimura, T
Argitaratua 1986

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabe...

nork Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Argitaratua izan da Diabetes Obes Metab (2015)